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Abstract
Objectives: The present study was designed to evaluate the usefulness of deep dry needling in the treatment of 
temporomandibular myofascial pain. 
Study Design: We selected 36 patients with myofascial pain located in the external pterygoid muscle (30 women/6 
men, mean age=27 years with SD±6,5). We studied differences in pain with a visual analog scale and range of 
mandibular movements before and after intervention. 
Results: We found a statistically significant relationship (p<0,01) between therapeutic intervention and the im-
provement of pain and jaw movements, which continued up to 6 months after treatment. Pain reduction was 
greater the higher was the intensity of pain at baseline. 
Conclusions: Although further studies are needed, our findings suggest that deep dry needling in the trigger point 
in the external pterygoid muscle can be effective in the management of patients with myofascial pain located in 
that muscle.
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Introduction
Temporomandibular joint (TMJ) is a bilateral diarthrosis 
located between the glenoid fossa-temporal eminence com-
plex and the mandibular condyle. Its involvement is mul-
tifactorial, and is commonly known by ambiguous terms 
such as temporomandibular disorder or TMJ pain-dysfunc-
tion syndrome. This condition is highly prevalent, and usu-
ally has varied clinical presentations characterized by pain 
in the preauricular area and alterations in the dynamic of 
open-close mouth movements. Painful hypersensitivity is 
often observed in the masticatory muscles as origin of myo-
fascial pain syndrome, being the external pterygoid mus-
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cle one of the most frequently affected. External pterygoid 
muscle (Pterygoideus lateralis) is a short, thick and flattened 
transversely muscle, located in the pterygomaxillary fossa 
roof that extends from the pterygoid process and greater 
wing of sphenoid to the neck of the mandibular condyle, be-
ing essential to the protrusive and lateral movements of the 
mandible (1,2).
Most authors agree that the current treatment of non-spe-
cific myofascial pain is multidisciplinary and must be ap-
proached from several perspectives. Myofascial pain must 
be suspected in patients with pain in masticatory muscles 
located in the preauricular or mandibular area, frontal or 
temporal regions, or in the ear, along with the existence of 
painful trigger points (TPs) on palpation. Usually, it is asso-
ciated with pain provoked by mandibular function and with 
limitation of interincisal opening (opening <40 mm) (3-9). 
Our study had the purpose of aiding to determine the pos-
sible importance of myofascial TPs in temporomandibu-
lar pathology, and evaluate the usefulness of the deep dry 
needling (DDN) in the treatment of myofascial pain of the 
external pterygoid muscle.
Material and Methods
We studied 36 patients with myofascial pain located in 
the external pterygoid muscle consecutively selected in 
the outpatient clinic of the Oral and Maxillofacial Surgery 
Department of “Virgen del Rocio” University Hospital 
of Seville (Spain), between May and September 2008, to 
compare differences in pain with a visual analog scale and 
range of mandibular movements before and after applica-
tion of needles for needling the external pterygoid mus-
cle. Patients were included in a diagnostic protocol based 
on clinical signs and imaging techniques (panoramic ra-
diograph and MRI). The study received prior approval 
from the Committee for Research and Clinical Ethics of 
the Hospital, and informed consent was obtained from 
all patients before inclusion in the study. We included pa-
tients older than 18 years of age with temporomandibular 
pain for more than six months and moderate limitation in 
mandibular movement (limitation of interincisal opening 
<40 mm and passive stretching to force the opening ≥ 5 
mm, according to I-b group criteria of the International 
RDC-TMD Consortium), and with a palpable taut band or 
hypersensitive nodule in the external pterygoid muscle mass 
by intraoral palpation. We excluded patients under 18 years 
and those with TMJ internal derangements with anterior 
disk displacement, degenerative joint disease (osteoarthri-
tis/osteoarthrosis), history of jaw trauma, vascular diseases, 
migraine and tension headaches, and history of infectious-
inflammatory conditions of odontogenic origin.
Sterile stainless steel needles with a plastic cylindri-
cal guide, 40 mm in length and 0.25 mm caliber dis-
tributed in Spain by Agu-punt®, have been used for 
the therapy with DDN. A total of 3 sessions were per-
formed per patient at an interval of 1 week, and clini-
cal assessments at 2 weeks, 1 month, 2 months and 6 
months after finishing the treatment. The needle was 
applied after asepsis of the preauricular area with alco-
hol 90%, manual location of the intra-extraoral mass 
of the external pterygoid muscle (Fig. 1), uni- or bi-
laterally, and intramuscular needling (Fig. 2), accord-
ing to the technique of Koole et al. modified without 
electromyographic control (10), followed by compres-
sive hemostasis for 1 minute. The needle was inserted 
perpendicularly through the skin taking into account 
the relationship between the muscle and TPs with the 
surrounding anatomical structures. That is why we con-
sidered necessary to know the exact location of the TP 
by palpation and pressure sensivity, and by asking the 
patient to perform a maximum opening that allowed us 
Fig. 1.  Anatomic location of the external pterygoid 
muscle for needling.
Fig. 2. Needling with a 40 mm. sterile needle and 
removal the plastic guide-tutor, followed by move-
ments of rotation and input-output to enhance the 
elimination of myofascial pain. 
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to avoid the bony structures that impeded the access to 
the external pterygoid muscle (coronoid process ahead, 
mandibular condyle behind, zygomatic arch above, and 
the sigmoid notch below). A jump or jerk reaction of 
the muscle (local twitch response) is often produced 
upon inserting the needle in the TP. If another TP can 
be detected in any of the other elevator muscles (tem-
poral, masseter and internal pterygoid muscles), these 
areas were inactivated before DDN of TP in the external 
pterygoid muscle; so that 4 patients of our study with 
TPs also in masseter muscle received, in addition to 
treatment with DDN, an  adjuvant treatment with deep 
tissue massage and manual stretching of the masseter 
muscle in order to prepare the treatment area (exter-
nal pterygoid muscle) by muscle relaxation of adjacent 
structures. The treatment was performed using deep 
needling in the myofascial TP without the introduction 
of any substance (dry needling). Four variables were 
measured: perceived or subjective pain by visual analog 
scale and range of mandibular movements by Therabite® 
System rule (mouth opening, laterality and protrusion 
movements). The signs that were assessed as indicative 
of the efficacy of DDN were: significant improvement of 
myofascial pain, recovery of the normal range of mouth 
opening, incisal straight path during open-close move-
ments, and absence of painful hipersensivity on palpa-
tion of external pterygoid muscle with disappearance of 
the TP. The statistical analysis of results was carried out 
with SPSS 15.0 software.
Results
Of the 36 patients studied, 30 (83.3%) were women and 6 
(16.6%) men. The mean age was 27 years (SD ± 6.5). Clini-
cal signs were: preauricular pain (in all cases) with a mean 
value of 8.45 ± 1.46 in visual analog scale, joint noise sounds 
in mouth opening (in 5 cases), and reduction in the range of 
mandibular movements (in all cases). Before DDN, mean 
mandibular movements values were: mouth opening of 2.90 
(± 1.10), laterality of 0.20 (± 0.01), and protrusion of 0.1 (± 
0.00). Radiographic findings showed no alteration in the 
morphology of the articular surfaces. MRI studies revealed 
no significant changes in static and dynamic position of the 
articular disk in any of the cases studied.
Table 1 shows the evolution of pain. After treatment, the 
pain was reduced in 6.5 points (SD ± 1.57). The mag-
nitude of pain reduction was statistically significant 
(p <0.01) in all controls performed. Mean mandibular 
movement at 6 months after the DDN were: mouth open-
ing of 4.50 cm (± 0.50), laterality of 1.20 cm (± 0.20), and 
protrusion of 0.6 cm (±0,01). In (Fig. 3) are represented 
Myofascial pain in the external pterygoid muscle (VAS) Average SD 
Initial pain (before treatment) 8,45 1,46 
Pain 2 weeks after DDN  2,25 0,81 
Pain 1 month after DDN  2,15 0,87 
Pain 2 months after DDN  2,05 0,75 
Pain 6 months after DDN  1,95 0,61 
Difference (initial pain-final pain) 6,50 1,57 
Table 1. Temporomandibular pain evolution before and after 
treatment with DDN, assessed by visual analogue scale (VAS).
DDN: deep dry needling. 
Fig. 3. Changes in pain, mouth opening, and protrusive and lateral movements, before and 6 months after DDN in the external pterygoid 
muscle. 
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the changes in pain and functional parameters (opening, 
lateral and protrusive movements) before and 6 months 
after DDN. 
By analyzing the correlation between pain assessment 
before the start and the end of treatment, we observed 
that greatest reductions in pain were achieved in 
those patients who had high baseline values in visual 
analog scale before starting treatment. On the con-
trary, when patients had low values of pain in visual 
analogue scale, less pain reduction was achieved. The 
pain response to DDN therapy was observed as early 
as 2 weeks after DDN, and remained stable without 
significant changes during the control patient period 
(Table 1). Also, the mandibular movement response 
(opening, laterality and protrusion) was observed in 
the first control at 2 weeks after DDN, showing no 
significant variation throughout the control period up 
to 6 months post-treatment.
Discussion
Temporomandibular pain of myofascial origin is a con-
dition often referred for evaluation to outpatient clin-
ics of Oral and Maxillofacial Surgery Departments. In 
more than 90% of cases no underlying cause is found, 
that is why they are diagnosed as nonspecific or un-
complicated pains, whose treatment is still under study 
(2,6,11).
Vazquez-Delgado et al. have reviewed the pathophysio-
logic, clinical and therapeutics aspects of the myofascial 
pain syndrome (12,13). Usual treatment of temporoman-
dibular myofascial pain in our working environment is 
a combination of pharmacological and splint therapy, 
which produces a temporary relief. However, pharma-
cological treatments soon reach the limit of therapeutic 
efficacy and they are also associated with side effects 
(gastrointestinal disorders, drug interactions, and ad-
verse reactions), so that the current trend is the search 
for alternative treatments (14-16).
Clinical guidelines and protocols about temporoman-
dibular disorders recommend the management of my-
ofascial pain from a multidisciplinary approach (3,4). 
However, within available treatments for muscle pain, 
there is a paucity of studies about the effectiveness of 
TP needling in masticatory muscles, and that is why we 
set the objective of studying the DDN of myofascial TP in 
the external pterygoid muscle. The mechanism of inactiva-
tion of a TP by needling is unknown, although we consider 
important the presence of a local twitch response during 
DDN, because it has a proven relationship with the desired 
therapeutic effect (6,17). Apparently, the tissular mechani-
cal disruption caused by needle insertion constitutes the 
specific therapy, but the mechanism of action by which the 
TP is disabled is unknown. According to Travell, it would 
be by the mechanical disruption of the self-sustaining 
mechanism of the TP due to the membrane depolarization 
of the nerve fibers provoked by the intracellular potassium 
release and interruption of the central feedback mecha-
nism (1,7). According to Hong, the most reasonable expla-
nation seems to be a neurological mechanism (18), because 
pain relief after the DDN happens often in few seconds, as 
we also observed in our study. Probably, local mechanical 
disruption or reflex central interruption are the most likely 
mechanisms for breaking the vicious circle of the phenom-
enon of myofascial TP (11,14,16).
Since by stretching techniques and manual handling is dif-
ficult and complicated to access to the external pterygoid 
muscle, needling of TPs may be necessary. The critical 
importance of this muscle as origin of temporomandibu-
lar myofascial pain makes it worthwhile to develop the 
necessary skills for invasive treatment by TP needling. 
The external approach (extraoral DDN) allows the nee-
dling of the central TPs in the muscle bellies of the two 
divisions of the muscle and in the insertional TPs of 
posterior myotendinous junctions of both divisions. The 
correct location of the muscle mass is essential for the 
technique we use, so interference factors represented by 
the nearby bony structures (zygomatic arch, coronoid 
process, condyle and sigmoid notch of the mandible) 
must be eliminated. That is why there is no need to car-
ry out the electromyographic control described in Koole 
et al. study (10), which is a complicated and uncomfort-
able technique that we do not think it is necessary in 
treating outpatients with DDN in which the TP can be 
detected by careful palpation and pressure sensitivity. 
Taut bands and TPs in the masseter muscle are other 
factors to consider as interference, since it can be diffi-
cult to recognize the pressure sensitivity on the external 
pterygoid muscle, which lies in a deeper layer. Masseter 
taut bands are more superficial and oriented almost 
perpendicularly to the fibers of the external pterygoid 
muscle making them easily distinguishable. Hypersen-
sitivity of TPs in the masseter muscle must be inacti-
vated before treatment of TPs in the external pterygoid 
muscle by DDN, as we did in 4 cases in our study.
In our patients we did not use a intramuscular puncture 
technique to inject local anesthetics, corticosteroids or 
botulinum toxin because DDN is just as effective in the 
myofascial pain caused by TPs in the pterygoid mus-
cle, and this way myotoxic effects of infiltration with 
such drugs are avoided. Myotoxicity is strongly related 
to the concentration of anesthetic injected, especially 
by long-lasting anesthetics. The use of epinephrine in 
concentrations of 1:100,000 or more can increase mus-
cle damage caused local anesthetics. The myotoxicity 
of the botulinum toxin type-A is irreversible by binding 
to the presynaptic cholinergic nerve terminals and in-
terrupting any neurogenic contraction of muscle fibers 
mediated by the affected motor plates. This chemical 
denervation maintains the paralysis of the muscle for a 
period of 3 to 6 months until new axons sprout from a 
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motor nerve and form new synaptic contacts to restore 
a normal neuromuscular junction function of affected 
muscle fibers (17).
For the treatment of symptoms associated with TPs, the 
DDN is a technique as effective as the infiltration of an-
esthetics if it causes local twitch response, which occurs 
when the needle had inserted in the muscular active loci 
of the TP. The reverse is also true and, if there is no lo-
cal twitch response, the DDN or the infiltration of anes-
thetics are equally ineffective. Another reason to prefer 
the DDN before using local anesthetics is because dry 
needling allows the location of all TPs from one area by 
preserving pain reaction to palpation.
The results of our study have shown that the greatest reduc-
tion in the magnitude of pain was achieved when patients 
had started from a more unfavorable clinical situation with 
intense pain, so it was expected that pain improvement 
would be more evident in these patients. We have observed 
that in those patients who had significant pain before start-
ing treatment (values 8 to 10 in visual analog scale), it was 
common that they had a reduction of 6 points, while those 
that started with mild pain (value less than 6) the expect-
ed reduction of pain was 4 points or less. These findings 
are consistent with the results published by other authors 
that performed intramuscular infiltrations after muscle 
needling (18,19). Fernández-Carnero et al. conducted a 
study with DDN in masseter muscle TPs in a group of 12 
women obtaining a good therapeutic outcome measured 
by increase in the threshold of pain caused by pressure 
and measured with algometer (15). Bubnov examined the 
DDN guided by ultrasound to increase the accuracy of the 
TP needling under visual verification, and obtained a pain 
reduction in 93.3% of patients in a group of 91 patients 
with myofascial pain in different locations (20).
In conclusion, the results of our study suggest that pa-
tients with painful temporomandibular disease due to 
external pterygoid muscle involvement treated selec-
tively with needles for dry needling showed a significant 
improvement in pain and, as consequence, an improve-
ment of functional limitation which persisted up to 6 
months after finishing the treatment. Pain reduction was 
greater the higher was the intensity of pain at baseline.
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